Symbol

    loading  Checking for direct PDF access through Ovid

Abstract

BACKGROUND:

Real-time quantitative RT-PCR can directly reflect the expression change of fusion gene, but it cannot directly reflect the relative expression of intracellular PML-RARα fusion protein in patients with acute promyelocytic leukemia (APL) before and after all-trans retinoic acid treatment.

OBJECTIVE:

To investigate the reliability of immunofluorescence technique in judging the early-stage therapeutic effects of all-trans retinoic acid treatment in APL by dynamic monitoring PML-RARα fusion protein.

METHODS:

Immunofluorescence technique was used for detection of PML-RARα protein expression in typical APL cell strain BN4 cells or NB4 cells of patients with APL following all-trans retinoic acid treatment. Real-time quantitative RT-PCR was used for detection of intracellular PML-RARα mRNA expression as control to investigate the reliability of immunofluorescence technique.

RESULTS AND CONCLUSION:

Immunofluorescence staining results showed that before all-trans retinoic acid treatment, a large amount of red fusion protein PML-RARα of different size and irregular morphology was observed in BN4 cells in vitro cultured or from patients’ bone marrow; after all-trans retinoic acid treatment, PML-RARα fusion protein in the NB4 cells gradually became regular and was gradually scattered with prolongation of treatment time. Real-time quantitative RT-PCR results showed that the change tendency of PML-RARα mRNA expression was in accordance with immunofluorescence results. This suggests that immunofluorescence for detection of PML-RARα expression can be used for directly judging the therapeutic effects of all-trans retinoic acid treatment.

RESULTS AND CONCLUSION:

Qiu F, Zhang H, Zhao XJ, Zhu XH, Wang KK, Zhang J. Immunofluorescence for dynamic monitoring of PML-RARα fusion protein in patients with acute promyelocytic leukemia.Zhongguo Zuzhi Gongcheng Yanjiu. 2012;16(10): 1875-1878.

Related Topics

    loading  Loading Related Articles